Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kempharm, Inc (KMPH)  
$8.50 0.10 (1.19%) as of 4:30 Fri 2/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 72,540,000
Market Cap: 616.59(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $6.56 - $12.79
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 9.5
Insider 3/6 Months : 10.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   KemPharm is a specialty pharmaceutical company focused on the discovery and development of treatments for central nervous system (CNS) and rare disease indications that allow it to target areas with unmet needs. Co.'s prodrug product candidate pipeline is focused on the idiopathic hypersomnia (IH) and other CNS/rare diseases. Co.'s approved product, AZSTARYS®, a once-daily treatment for attention deficit hyperactivity disorder in patients, age six years and older, contains its prodrug, serdexmethylphenidate (SDX). Co.'s primary clinical development product candidate, KP1077, is based on SDX, its prodrug of d-methlyphenidate and is in development for the treatment of IH and narcolepsy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 28,175 38,475 60,975
Total Buy Value $0 $228,343 $310,319 $454,543
Total People Bought 0 3 4 6
Total Buy Transactions 0 3 5 9
Total Shares Sold 132,863 152,363 206,907 292,680
Total Sell Value $1,223,947 $1,434,855 $1,901,821 $2,575,835
Total People Sold 5 5 5 6
Total Sell Transactions 8 9 11 15
End Date 2025-11-16 2025-08-15 2025-02-14 2024-02-15

   
Records found: 165
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mcfarlane Neil F. President and CEO   •       •      –    2026-02-09 4 AS $8.56 $125,186 D/D (14,625) 387,225     -
   Mcfarlane Neil F. President and CEO   •       •      –    2026-02-07 4 OE $0.00 $0 D/D 37,500 401,850     -
   Sangiovanni Timothy J. SVP, Finance & Corp Controller   •       –      –    2026-02-03 4 AS $9.18 $27,548 D/D (3,000) 29,590 -6%     
   Schafer Joshua CCO   •       –      –    2026-02-03 4 AS $9.19 $96,500 D/D (10,500) 62,278 -6%     
   Mcfarlane Neil F. President and CEO   •       •      –    2026-02-02 4 AS $9.38 $853,425 D/D (91,000) 364,350 -8%     
   Schafer Joshua CCO   •       –      –    2026-01-31 4 OE $0.00 $0 D/D 35,334 72,778     -
   Sangiovanni Timothy J. SVP, Finance & Corp Controller   •       –      –    2026-01-31 4 OE $0.00 $0 D/D 11,666 32,590     -
   Mcfarlane Neil F. President and CEO   •       •      –    2026-01-31 4 OE $0.00 $0 D/D 233,334 455,350     -
   Schafer Joshua CCO   •       –      –    2026-01-30 4 AS $8.83 $29,800 D/D (3,375) 37,444 -4%     
   Schafer Joshua CCO   •       –      –    2026-01-30 4 OE $0.00 $0 D/D 11,333 40,819     -
   Thompson Rahsaan Chief Legal & ComplianceSecret   •       –      –    2026-01-30 4 AS $8.83 $36,010 D/D (4,080) 49,919 -4%     
   Thompson Rahsaan Chief Legal & ComplianceSecret   •       –      –    2026-01-30 4 OE $0.00 $0 D/D 11,333 53,999     -
   Quartel Adrian W Chief Medical Officer   •       –      –    2026-01-30 4 AS $8.83 $40,036 D/D (4,533) 9,723 -4%     
   Quartel Adrian W Chief Medical Officer   •       –      –    2026-01-30 4 OE $0.00 $0 D/D 11,333 14,256     -
   Sangiovanni Timothy J. SVP, Finance & Corp Controller   •       –      –    2026-01-30 4 AS $8.82 $15,442 D/D (1,750) 20,924 -4%     
   Sangiovanni Timothy J. SVP, Finance & Corp Controller   •       –      –    2026-01-30 4 OE $0.00 $0 D/D 6,333 22,674     -
   Clifton R. Laduane Former CFO & Treasurer   –       –      –    2025-12-31 4 D $8.96 $434,676 D/D (48,513) 143,515     -
   Clifton R. Laduane Former CFO & Treasurer   –       –      –    2025-12-31 4 OE $0.00 $0 D/D 140,667 192,028     -
   Mcfarlane Neil F. President and CEO   •       •      –    2025-10-10 4 AS $10.82 $210,908 D/D (19,500) 222,016 -22%     
   Mcfarlane Neil F. President and CEO   •       •      –    2025-10-10 4 OE $0.00 $0 D/D 50,000 241,516     -
   Seymour Tamara A Director   –       •      –    2025-09-12 4 B $7.79 $24,718 D/D 3,175 3,894 2.39 17%     
   Shih Alvin Director   –       •      –    2025-09-12 4 B $7.89 $157,800 D/D 20,000 20,000 2.39 17%     
   Bode John B Director   •       •      –    2025-08-19 4 B $9.17 $45,825 D/D 5,000 45,000 2.39 -2%     
   Thompson Rahsaan Chief Legal & ComplianceSecret   •       •      –    2025-06-26 4 AS $9.21 $221,004 D/D (24,000) 42,666 10%     
   Thompson Rahsaan Chief Legal & ComplianceSecret   •       •      –    2025-06-21 4 OE $0.00 $0 D/D 66,666 66,666     -
  165 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us